In today’s ACT Brief, we examine how sites can avoid both fear-driven and overly aggressive AI adoption, why community-based research needs sustained financial investment, and why patient access matters more than organizational size.
News|Podcasts|December 27, 2024
Our Top 5 Podcast Episodes of 2024
Author(s)Miranda Schmalfuhs
The top five episodes of our podcast in the year 2024, highlighted.
1. AI in Clinical Trials: A Long, But Promising Road Ahead
Stephen Pyke, chief clinical data and digital officer, Parexel discusses:
- A broad overview of the use of artificial intelligence in clinical development and how regulatory bodies are viewing it
- How AI can be used in clinical trials to streamline operational processes
- The importance of collaboration and data sharing in advancing the use of technology, and more
- The importance of considering the experience of patients when integrating artificial intelligence as well as some of the benefits they will see from it
- Human oversight when using artificial intelligence to aid in decision making
2. Diversity in Clinical Trials: The Need to Take Action
Gadi Saarony, CEO of Advarra examines:
- The current state of diversity in clinical research
- The need for industry to take more action in making trials more diverse
- What regulatory bodies need to do to increase awareness
- How researchers can best reach diverse populations
3. Including Women of Childbearing Age in Clinical Research
Marie Teil, Global Head of UCB’s Women of Childbearing Age Program, discusses:
- Specific challenges women with chronic illnesses face when accessing appropriate treatment and participating in clinical trials
- UCB's Women of Childbearing Age Program and it’s most successful strategies
- The role of technology in addressing the data gap in women's health research
4. Bringing the Clinical Trials Industry Together
Micah Lieberman, Executive Director, Conferences (CHI) & Co-Founder, VP, Community and Business Development (ClinEco) shares:
- The origin story of ClinEco
- Why he felt the clinical trials industry needed a more centralized ecosystem
- The SCOPE Europe conference and more!
5. Managing Digital Studies in the Current Landscape
Flo Mowlem, VP of Science at ObvioHealth:
- Highlights her career path and experience with eCOA
- Discusses what is currently happening in the digital clinical trials space
- & How to manage the unique challenges they bring including device accessibility and remote patient monitoring
Related to this article
In today’s ACT Brief, we examine how AI is moving into continuous clinical operating models, how trust is built into oncology real-world evidence, and how the FDA approved a self-administered option for thyroid eye disease.
In today’s ACT Brief, we examine who decides what trials measure, how designing for human thinking improves site execution, and how the FDA extended an immunotherapy to a new bladder cancer population.
In Episode 3 of The Human Side of Clinical Trials, hosts Brian S. McGowan, PhD, FACEHP, chief learning officer and co-founder of ArcheMedX, Inc., and Kelly Ritch, chief operating officer of ArcheMedX, Inc., speak with Jason Riis, PhD, CEO and chief behavioral scientist at Behavioralize, about why a well-written protocol doesn’t always translate into consistent execution, and how designing for the way people actually think and learn can reduce site burden and the need for costly unlearning.
In today’s ACT Brief, we examine what it will take to scale EHR-to-EDC connections for real-time trials, how the FDA is reimagining rare disease drug development, and why oncology real-world evidence still faces persistent data barriers.
In today's ACT Brief, we examine how representation gaps in trials are shaped by structural design decisions, how new partnerships automate data transfer from site systems to sponsor platforms, and how Roche is licensing a novel obesity target from a biotech pioneer.
Trending on Applied Clinical Trials Online
1
Clinical Trials Do Not Have a Data Problem, They Have a Decision-Readiness Problem
2
Building Standardized Evidence for eSource-Enabled Clinical Trials: Multi-Site Validation of a Clinical Research Coordinator Satisfaction Methodology
3
Where the Industry Is Headed as Clinical, Operational, and Real-World Data Connect
4
ACT Brief: Orchestrated AI Clinical Environments, eSource Coordinator Satisfaction, and Faster Clinical Trials Act
5